Exthymic Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Early Stage VC
- Investors
-
6
Exthymic General Information
Description
Operator of a biotechnology company intended to focus on democratizing access to autologous cell therapies through point-of-care manufacturing. The company is currently operating in Stealth mode.
Contact Information
Website
www.exthymic.comCorporate Office
- 3033 Science Park Road
- Suite 250
- San Diego, CA 92121
- United States
Corporate Office
- 3033 Science Park Road
- Suite 250
- San Diego, CA 92121
- United States
Exthymic Timeline
Exthymic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 01-Jan-2026 | Completed | Startup | |||
| 2. Accelerator/Incubator | 11-Mar-2025 | Completed | Startup | |||
| 1. Early Stage VC | 13-May-2024 | $10.2M | $10.2M | Completed | Startup |
Exthymic Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Exthymic Patents
Exthymic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026039684-A1 | Systems and methods for manipulation or evaluation of a biological sample | Pending | 16-Aug-2024 | ||
| US-10488321-B2 | Devices and methods for high-throughput single cell and biomolecule analysis and retrieval in a microfluidic chip | Active | 19-Mar-2015 | ||
| US-20180067038-A1 | Devices and methods for high-throughput single cell and biomolecule analysis and retrieval in a microfluidic chip | Active | 19-Mar-2015 |
Exthymic Signals
Exthymic Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hawktail | Venture Capital | Minority | ||
| Phase Two Ventures | Venture Capital | Minority | ||
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Alix Ventures | Venture Capital | Minority | ||
| Dimension (United States) | Venture Capital | Minority |
Exthymic FAQs
-
When was Exthymic founded?
Exthymic was founded in 2023.
-
Where is Exthymic headquartered?
Exthymic is headquartered in San Diego, CA.
-
What is the size of Exthymic?
Exthymic has 14 total employees.
-
What industry is Exthymic in?
Exthymic’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Exthymic a private or public company?
Exthymic is a Private company.
-
What is Exthymic’s current revenue?
The current revenue for Exthymic is .
-
How much funding has Exthymic raised over time?
Exthymic has raised $10.2M.
-
Who are Exthymic’s investors?
Hawktail, Phase Two Ventures, CONNECT (San Diego), Alix Ventures, and Dimension (United States) are 5 of 6 investors who have invested in Exthymic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process